Edwards Lifesciences wins Novation three-year "new technology" deal:
This article was originally published in Clinica
Executive Summary
Edwards Lifesciences is to supply US group purchasing organisation Novation with its range of central venous oximetry catheters, including the PreSep catheters used for early assessment of sepsis. Edwards was awarded the single-source, three-year deal through Novation's new technology evaluation, which fast-tracks the review process for new and improved technologies, so that the product's manufacturer would not have to bid for the deal through a scheduled, competitive process.